CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
NCT05467683
This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
Anxiety-, obsessive-compulsive and trauma- and stressor-related disorders reflect a significant public health problem. This study is designed to evaluate the predictive power of a novel biomarker based on a CO2 challenge, thus addressing the central question "can this easy-to-administer assay aid clinicians in deciding whether or not to initiate exposure-based therapy?"
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Obsessive-Compulsive Disorder
- Post Traumatic Stress Disorder
- Generalized Anxiety Disorder
- Social Anxiety Disorder
- Panic Disorder
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Jasper A. Smits
- Last updated on ClinicalTrials.gov
- June 10, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 1
- Boston University · Boston, MA
Texas · 1
- The University of Texas at Austin · Austin, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.